Primary malignant melanoma of the cervix: Report of 14 cases and review of literature

Guangwen Yuan; Lingying Wu; Bin Li; Jusheng An

doi:10.18632/oncotarget.17183

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Clinical Research Papers:

Primary malignant melanoma of the cervix: Report of 14 cases and review of literature

Guangwen Yuan, Lingying Wu _, Bin Li and Jusheng An

PDF | HTML | How to cite

Oncotarget. 2017; 8:73162-73167. https://doi.org/10.18632/oncotarget.17183

Metrics: PDF 1293 views | HTML 2955 views | ?

Abstract

Guangwen Yuan1, Lingying Wu1, Bin Li1 and Jusheng An1

1Department of Gynecologic Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, 100021, China

Correspondence to:

Lingying Wu, email: [email protected]

Keywords: malignant melanoma, treatment, cervix, prognosis

Received: January 31, 2017 Accepted: March 27, 2017 Published: April 18, 2017

ABSTRACT

Purpose: To investigate the clinical characteristics and prognosis of primary malignant melanoma of the uterine cervix.

Results: The median age of the patients was 61.2 years (range, 42-78 years). The median overall survival of the patients at stage I, II and III were 39.2 months, 47.8 months and 9.0 months (P=0.574) and the 2-year overall survival for each stage were 80.0%, 50.0% and 0.0% respectively. Twelve (85.7%) patients developed recurrence and eleven patients (78.6%) died. Ten patients received surgery and four patients were treated with chemotherapy and/or radiotherapy. Immunotherapy was administrated to two patients after surgery. The mean survival time of patients with surgery and without surgery were 47.9 vs.7.75 months (P=0.047). Patients received radical hysterectomy had longer survival than patients underwent total hysterectomy (66.8 months vs 19.5 months, P=0.016).

Methods: Clinical data from 14 patients with primary malignant melanoma of the cervix between January 1981 and December 2014 were reviewed.

Conclusions: Patients with primary malignant melanoma of the cervix have a poor prognosis. Radical hysterectomy and pelvic lymphnode dissection may offer better prognosis for stage I and II patients.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 17183

Publication Alerts

Post-Publication Promotion

Clinical Research Papers:

Primary malignant melanoma of the cervix: Report of 14 cases and review of literature

Abstract